Freenome, Inc. Common stock (FRNM NASDAQ) stock market data APIs
$14.9261
0.61(4.1%)
as of September 10, 2026
Try our APIs with
free plan!
Freenome, Inc. Common stock Financial Data Overview
Price chart is built with
Anychart
Freenome, Inc. operates as a biotechnology company in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops blood-based tests, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.
Prev. Close
14.9261
Open
15.5392
High
15.7417
Low
14.8577
52 wk Range
9.95-17.175
Market Cap
1 692 M
Shares Outstanding
107 M
Revenue
35 410 K
EPS
-0.0111
Beta
0.477
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Freenome, Inc. Common stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Freenome, Inc. Common stock data using free add-ons & libraries
Get Freenome, Inc. Common stock Fundamental Data
Freenome, Inc. Common stock Fundamental data includes:
- Net Revenue: 35 410 K
- EBITDA: -206 008 992
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Freenome, Inc. Common stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Freenome, Inc. Common stock News
New
Cathie Wood sells $4 million of surging AI stock
Cathie Wood, chief of Ark Investment Management, often trims her biggest winners after sharp rallies. This week, she's selling Tempus AI (TEM), taking some shares off the table after the healthcare A...
Jefferies sets strong price target on upstart cancer stock
Freenome (FRNM) only started trading publicly via a Special Purpose Acquisition Company, or SPAC, deal a few weeks ago on July 21, 2026. While Freenome isn't nearly as familiar to investors as large ...
Guardant Health, Thursday's Stock Of The Day, Spikes After Hiking 2026 Outlook
Guardant Health is Thursday's IBD Stock Of The Day in a thriving market for colon cancer screening tests. On Friday, Guardant Health stock surged after the company raised full-year outlook after a Q2...
Guardant Health, Stock Of The Day, Offers Entry With Earnings Due
Guardant Health is the IBD Stock Of The Day in a thriving market for colon cancer screening tests. Health and biotech stocks are acting well in the current market. Several biotech and health names can be found on the IBD 50 list of top growth stocks. Continue Reading
Get Freenome, Inc. Common stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
